Policy Headwinds Stall Growth as CYH Cuts 2026 Revenue and EBITDA Guidance
Community Health Systems reports weak 2Q26 results and trims full-year revenue and EBITDA guidance, citing policy headwinds. The stock is rated Sell given the declines. Cash flow is weakening as insurance payment delays add to operational strain, while leverage stays high at about 6.7x. The company uses divestitures to help manage debt.